Recent Quotes (30 days)

You have no recent quotes
chg | %

MedX Health Corp.  

(Public, CVE:MDX)   Watch this stock  
Find more results for MDX
-0.015 (-9.68%)
Delayed:   10:12AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.14 - 0.14
52 week 0.05 - 0.27
Open 0.14
Vol / Avg. 41,500.00/161,312.00
Mkt cap 16.96M
P/E     -
Div/yield     -
EPS -0.01
Shares 97.69M
Beta -0.10
Inst. own     -

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -144.82% -42.62%
Operating margin -144.82% -42.62%
EBITD margin - -54.41%
Return on average assets -203.49% -88.36%
Return on average equity - -
CDP Score - -


1495 Bonhill Rd Unit 1
+1-905-6704428 (Phone)
+1-905-6704749 (Fax)

Website links


MedX Health Corp. is a medical device company. The Company is focused on research, development, manufacturing and distribution of phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode (LED). Its products are offered to the rehabilitation market for treating pain, tissue damage, swelling and inflammation. It offers SIAscopy, which is a medical device that is used to scan suspicious moles and lesions. Its SIMSYS-MoleMate Skin Imaging System is a non-invasive skin screening procedure for moles and lesions. Its SIMSYS uses SIAscopy providing detail and information from approximately two millimeters beneath the skin. Its MoleMate is a non-invasive, rapid and painless screening device that has been designed with and for general practitioners and skin specialists. Its SIAMETRICS allows cosmetic formulators and active ingredient manufacturers to measure and quantify the concentrations of melanin, hemoglobin and collagen in living human skin.

Officers and directors

Steven T. Guillen Chairman of the Board
Robert Gerhard von der Porten President, Chief Executive Officer, Director
Jim Cooke CPA Chief Financial Officer
Louie Canitano Chief Operating Officer
David J. Hennigar Independent Director
Kenneth McKay Independent Director
N. Gary Van Nest Independent Director